|
TOP2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.389800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.237000E-03 |
| Normal-vs-Stage2 |
6.755100E-04 |
| Normal-vs-Stage3 |
1.623990E-04 |
| Normal-vs-Stage4 |
5.96539999999646E-05 |
| Stage1-vs-Stage2 |
2.866600E-01 |
| Stage1-vs-Stage3 |
1.743010E-01 |
| Stage1-vs-Stage4 |
2.556200E-02 |
| Stage2-vs-Stage3 |
9.090000E-01 |
| Stage2-vs-Stage4 |
4.124600E-01 |
| Stage3-vs-Stage4 |
4.512600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.807200E-04 |
| Normal-vs-AfricanAmerican |
6.577200E-04 |
| Normal-vs-Asian |
1.177190E-01 |
| Caucasian-vs-AfricanAmerican |
5.901400E-01 |
| Caucasian-vs-Asian |
9.531200E-01 |
| AfricanAmerican-vs-Asian |
7.817600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.73369999998141E-06 |
| Normal-vs-Female |
9.470200E-01 |
| Male-vs-Female |
7.039400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.783860E-03 |
| Normal-vs-Extreme_Weight |
8.22960000000927E-05 |
| Normal-vs-Obese |
4.901900E-03 |
| Normal-vs-Extreme_Obese |
4.001600E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.070000E-01 |
| Normal_Weight-vs-Obese |
5.113400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.356200E-01 |
| Extreme_Weight-vs-Obese |
2.489800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.993400E-01 |
| Obese-vs-Extreme_Obese |
3.739000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.153200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.476600E-03 |
| Normal-vs-Age(61-80Yrs) |
3.615800E-04 |
| Normal-vs-Age(81-100Yrs) |
7.016000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.201600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.787900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.747900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.268000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.253400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.430200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.600200E-03 |
| Normal-VS-Type2 PRCC |
4.31580005066934E-09 |
| Normal-VS-KIRP CIMP |
2.182800E-01 |
| Normal-VS-Unclassified PRCC |
2.157700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.35119999999933E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.463400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.238400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.735830E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.884430E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.164400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.41539999959961E-07 |
| Normal-vs-N1 |
4.000900E-03 |
| Normal-vs-N2 |
1.336400E-02 |
| N0-vs-N1 |
1.593580E-01 |
| N0-vs-N2 |
9.859800E-01 |
| N1-vs-N2 |
5.324800E-01 |
|
|
